Product

DYMISTA®

Name

DYMISTA

INN Name

Azelastine Hydrochloride and Fluticasone Propionate

FDA Approved

Yes

1 clinical trial

1 organization

1 indication

1 document

Indication

Allergic Rhinitis

Clinical trial

National, Multicenter, Randomized, Double-blind, Phase III Clinical Trial to Evaluate the Efficacy and Safety of MAZ-101 in the Treatment of Persistent Allergic Rhinitis (PER)

Status: Not yet recruiting, Estimated PCD: 2024-11-01

Document

DailyMed Label: DYMISTA

Organization

Meda Pharmaceuticals Inc.